Inventor · Hartland, MI, US

Chad A. VanHuis

15Patents
5h-index
21Co-inventors
58Inventor score

Filing activity: Dec 10, 2014 → Mar 9, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9663502B2 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 12 Active
US9783511B2 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 9 Active
US9809561B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 8 Active
US10221146B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 6 Active
US9896441B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 6 Active
US9580388B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 4 Active
US10364237B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active
US10442798B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active
US10421751B2 Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active
US9815791B2 Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Human Necessities 1 Active
US9932313B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 1 Active
US10611740B2 Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 1 Active
US11059796B2 Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 0 Active
US10556898B2 Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease Chemistry; Metallurgy 0 Active
US10745364B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.